2026 Commercial Trade & Distribution
Monitoring & Measuring for Peak Performance:
A Strategic Framework for Building High-Performing Commercial Trade & Distribution Organizations
Download the 2026 Commercial Trade & Distribution White Paper
Commercial Trade & Distribution has become one of the most strategic functions within pharmaceutical commercialization. Decisions made by Trade organizations influence launch readiness, specialty pharmacy performance, gross-to-net, distributor relationships, patient access, regulatory compliance, and ultimately commercial success.
Our whitepaper provides a comprehensive framework of best practices, recommended KPIs, governance models, and performance measures developed from decades of industry experience and interviews with Trade leaders across the pharmaceutical ecosystem.
But the real value isn't simply reading the framework. Curatio works with manufacturers to benchmark their existing Trade organization, evaluate their KPIs, governance processes, distribution network performance, specialty pharmacy strategies, and commercial analytics, then develop actionable improvement plans that strengthen organizational performance and prepare them for future launches.
Curatio Advisors is helping manufacturers answer questions like:
Are we measuring the right things?
- KPI assessment
- Performance benchmarking
- Executive scorecard development
Are our distributors and specialty pharmacies performing?
- Distributor scorecards
- Specialty pharmacy performance frameworks
- Service fee measurement
- Fair Market Value support
Are we ready for launch?
- Launch readiness assessments
- Commercial command center design
- Early commercialization dashboards
Can we turn data into better decisions?
- KPI dashboard design
- Trade analytics
- AI-enabled performance monitoring
- Predictive commercial intelligence
Every manufacturer measures performance. Few know whether they're measuring the right things.
Curatio Advisors helps pharmaceutical manufacturers benchmark Commercial Trade & Distribution organizations, identify performance gaps, develop executive KPI frameworks, optimize distribution and specialty pharmacy networks, strengthen governance, and build the analytics capabilities needed to improve commercialization performance.
Schedule a complimentary Commercial Trade KPI Assessment to learn how your organization compares to industry best practices.
Curatio Scientia Advisors releases the “2023 Patient Access: State Legal and Regulatory Environment Survey”
Given the dynamic nature of state government activity we sought to validate the following:
- Patient access to prescription drug therapy is greatly affected by various state and local policy and regulatory parameters.
- There is no formalized process or aggregating compendium, at the state level, specifically monitoring policy and regulatory parameters that impact patient access to, and affordability of, drug therapies.
- Timely insights into legislation and regulations pertaining to patient access, particularly for high-cost drug therapies will enable more effective decisions regarding the patient’s journey and drug product lifecycle.